Influenza virus is an important human pathogen that can cause severe disease and death in humans. Highly pathogenic influenza viruses, such as H5N1, induce excessive host responses that are associated with the production of pro-inflammatory cytokines, the recruitment of innate immune cells, and a diminished adaptive immune response. Unfortunately, the host and viral proteins involved in this pathogenic response are largely unknown. Accordingly, elucidating the mechanisms that underlie the host response to influenza virus is critical and will provide a framework for the rational design of new therapeutics for the treatment of pathogenic influenza infection. Genetic variation of the host can significantly influence the outcome of infection. In humans, polymorphisms in interferon regulatory factor 7 (IRF7) and interferon-induced transmembrane protein 3 (IFITM3) cause a predisposition to severe influenza disease, highlighting their importance in the pathogenesis of influenza. To identify additional host factors that modulate influenza disease, we took advantage of the increased susceptibility of the A/J mouse strain to highly pathogenic H5N1 influenza virus. Using a series of C57BL/6 mice harboring individual chromosomes from the A/J strain, we identified a single chromosome that increased the observed susceptibility to highly pathogenic H5N1 influenza virus relative to control animals. The increased susceptibility in the parent consomic strain was associated with higher viral loads in the lungs as well as increased production of pro-inflammatory cytokines, which are hallmarks of a severe H5N1 infection in humans. This proposal is aimed at (1) identifying the host factor that modulates virus replication and increased lethality after H5N1 virus infection and (2) determining the mechanism by which the identified factor exacerbates the disease. Successful completion of the proposed studies will lead to the identification of a novel host factor associated with severe disease.

Public Health Relevance

Highly pathogenic H5N1 influenza virus causes severe disease and death in humans and represents a significant threat to public health. Accordingly, this project is aimed at identifying a novel host factor that regulates susceptibility to H5N1 influenza virus. The discovery of host factors that modulate influenza disease will provide critical insight into the biology of the H5N1 virus and could aid in the identification of novel therapeutics for the treatment of this deadly disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI137450-01
Application #
9505295
Study Section
Virology - B Study Section (VIRB)
Program Officer
Lane, Mary Chelsea
Project Start
2018-05-15
Project End
2020-04-30
Budget Start
2018-05-15
Budget End
2019-04-30
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130